Skip to main content
S 920 115th Congress Senate Health Advisory bodies Department of Health and Human Services Digestive and metabolic diseases Executive agency funding and structure Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Immunology and vaccination

National Clinical Care Commission Act

Introduced: April 24, 2017 Introduced by: Shaheen, Jeanne Democratic · New Hampshire See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 20 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 2, 2017
Became Public Law No: 115-80.
Nov 2, 2017
Signed by President.
Oct 24, 2017
Presented to President.
Oct 11, 2017
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H7946)
Oct 11, 2017
DEBATE - The House proceeded with forty minutes of debate on S. 920.
Oct 11, 2017
Mr. Olson moved to suspend the rules and pass the bill.
Oct 11, 2017
Considered under suspension of the rules. (consideration: CR H7946-7948)
Oct 11, 2017
Motion to reconsider laid on the table Agreed to without objection.
Oct 11, 2017
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H7946)
Sep 7, 2017
Held at the desk.
Sep 7, 2017
Received in the House.
Sep 7, 2017
Message on Senate action sent to the House.
Sep 6, 2017
Measure laid before Senate by unanimous consent. (consideration: CR S5019-5020)
Sep 6, 2017
Passed Senate with amendments by Unanimous Consent. (text: CR S5019-5020)
Sep 6, 2017
Passed/agreed to in Senate: Passed Senate with amendments by Unanimous Consent.(text: CR S5019-5020)
May 1, 2017
Placed on Senate Legislative Calendar under General Orders. Calendar No. 47.
May 1, 2017
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander without amendment. Without written report.
Apr 26, 2017
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Apr 24, 2017
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Apr 24, 2017
Introduced in Senate
 Plain-English summary Congressional Research Service

(This measure has not been amended since it was passed by the Senate on September 6, 2017. The summary of that version is repeated here.)

National Clinical Care Commission Act

(Sec. 2) This bill establishes within the Department of Health and Human Services (HHS) a National Clinical Care Commission to evaluate and make recommendations regarding improvements to the coordination and leveraging of federal programs related to complex metabolic or autoimmune diseases that result from issues related to insulin and represent a significant disease burden (e.g., diabetes). The commission must report on: (1) HHS programs that focus on prevention, (2) current activities and gaps in federal efforts to support clinicians in providing integrated care, (3) improvement in federal education and awareness activities related to prevention and treatment, (4) methods for outreach and dissemination of education and awareness materials, and (5) opportunities for consolidation of overlapping federal programs.

The commission must submit an operating plan to HHS and Congress within 90 days of its first meeting. The commission is terminated after it submits a final report, but not later than the end of FY2021.

What's happening now November 2, 2017

Became Public Law No: 115-80.

 Committees of jurisdiction 1
 Cosponsors 2
All 2 Democratic 1 Republican 1